Last reviewed · How we verify
NCT05106231: EPICCIHKDMEP
Effectiveness of PICC Improving HBA1C and Knowledge in Diabetes Mellitus Education
NA trial testing PICC Program in Diabetes Mellitus in 94 participants. Completed in 31 December 2023.
31 December 2023
Quick facts
| Lead sponsor | Clinical Research Centre, Malaysia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | sequential |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 94 |
| Start date | 1 May 2023 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 9 locations across Malaysia |
Drugs / interventions tested
- PICC Program
- Control
Conditions studied
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
- Type2 Diabetes — all drugs for Type2 Diabetes →
Sponsor
Clinical Research Centre, Malaysia
Who can join
18 and older, any sex, with Diabetes Mellitus or Type2 Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Ministry of Health Malaysia designs an education program for diabetes mellitus under the "Know Your Medicine" campaign. The Pharmacy Integrated Community Care (PICC) program hopes to improve knowledge and self-care for diabetes mellitus patients. PICC contains four modules that will provide knowledge on diabetes mellitus in an interactive, easily understandable and fun program. The investigators want to evaluate the program's effectiveness to see its relevance to Malaysian. PICC is an education program to give knowledge on diabetes mellitus to patients. It intended to improve self-care knowledge for patients with underlying Type 2 Diabetes Mellitus conducted the whole of Malaysia. However, in Sarawak, the investigators interested in conducting it together with this is an experimental study aiming to examine PICC's effectiveness. The study is being conducted in the nine Sarawak divisions. A minimum of 94 respondents will be participating in this study. Patient profile details will be taken with strict confidentiality.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effectiveness of a pharmacist-led, community group-based education programme in enhancing diabetes management: A multicentre randomised control trial.
Ahmad K, Anchah L, Ting CY, Lim SE. · · 2024 · cited 1× · PMID 38435429 · DOI 10.1016/j.conctc.2024.101280
Verify or expand the search:
- PubMed search for NCT05106231
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes Mellitus
Currently open trials in the same condition.
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
- NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
- NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
- NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting
Other Clinical Research Centre, Malaysia trials
Trials by the same sponsor.
- NCT06293508 — mHealth Behavioural Intervention to Increase Breast Cancer Screening Rates Among Members of the Public · NA · terminated
- NCT05895721 — Virtual Reality for Generalized Anxiety Disorders · NA · unknown
- NCT05638919 — Real World COVID-19 Antiviral Effectiveness Research · unknown
- NCT06163976 — Prognostic Modelling for Prediction of Mortality and Functional Disability in Critically-ill Elderly Patients · unknown
- NCT06128096 — The Effect of SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac Function in T2DM Patients With CAD (EpiCAD) · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05106231 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Clinical Research Centre, Malaysia
- Last refreshed: 16 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05106231.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing